Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s ...

There are strict rules around reporting a whole range of common health complaints affecting millions of people ...

The DVLA has confirmed a list of 118 conditions that all motorists must declare to avoid being penalised. This is the ...

Earlier this month, Biohaven Ltd. announced it received a Complete Response Letter from the FDA declining approval of its drug candidate VYGLXIA (troriluzole) for spinocerebellar ataxia, prompting the ...

MUM Nicky Starkowitz felt like she’d been “hit by a train” when her son Raffi was handed his cancer diagnosis. The only clue ...

Avian influenza virus cases tend to rise during the colder months, as is the case with human influenza. However, since 2020, ...

The Oxford-Harrington Rare Disease Centre ('OHC') today announced the recipients of the 2025 Rare Disease Scholar Award, which advances promising discoveries from academic labs into clinical practice.

The AI model in news offers deeper insight into protein-to-protein talk, advancing innovation in understanding mutations, ...

Ten scientists selected for second annual award to pursue innovations in gene, RNA, small molecule and cell therapies to treat rare and ultra-rare diseases OXFORD, England ...

The court heard how Wilkins’ dog, Roxy, was left at a veterinary practice in Plymouth on Friday, September 27 last year by an anonymous individual. Upon examination, staff discovered the grey jumper ...

Detailed price information for Solid Biosciences Inc (SLDB-Q) from The Globe and Mail including charting and trades.

Investigators who designed a base-editing treatment are planning an "umbrella of umbrellas" trial, while others are developing roadmaps to guide personalized treatments.